Literature DB >> 11575977

Is "isolated home" hypertension as opposed to "isolated office" hypertension a sign of greater cardiovascular risk?

G Bobrie1, N Genès, L Vaur, P Clerson, B Vaisse, J M Mallion, G Chatellier.   

Abstract

BACKGROUND: The SHEAF (Self-Measurement of Blood Pressure at Home in the Elderly: Assessment and Follow-up) study is an observational study (from February 1998 to early 2002) designed to determine whether home blood pressure (BP) measurement has a greater cardiovascular prognostic value than office BP measurement among elderly (> or =60 years) French patients with hypertension. The objective of this present work is to describe the baseline characteristics of the treated patients in the SHEAF study from February 1998 to March 1999, placing special emphasis on "isolated office" and "isolated home" hypertension.
METHODS: Baseline office BP measurement was assessed using a mercury sphygmomanometer. Home BP measurement was performed over a 4-day period. A 140/90-mm Hg threshold was chosen to define office hypertension, and a 135/85-mm Hg threshold to define home hypertension.
RESULTS: Of the 5211 hypertensive patients in the SHEAF study with a valid home BP measurement, 4939 received treatment with at least 1 antihypertensive drug. Patients with isolated office hypertension represented 12.5% of this population, while patients with isolated home hypertension represented 10.8%. The characteristics of the patients with isolated office hypertension were similar to those of patients with controlled hypertension. However, patients with isolated office hypertension had fewer previous cardiovascular complications. In contrast, rates of cardiovascular risk factors and history of cardiovascular disease in patients with isolated home hypertension resembled those in patients with uncontrolled hypertension.
CONCLUSIONS: This retrospective analysis suggests that patients with isolated home hypertension belong to a high-risk subgroup. The 3-year follow-up of these patients will provide prospective data about the cardiovascular prognosis of these subgroups.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11575977     DOI: 10.1001/archinte.161.18.2205

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  20 in total

Review 1.  Standards of medical care in diabetes--2012.

Authors: 
Journal:  Diabetes Care       Date:  2012-01       Impact factor: 19.112

2.  Standards of medical care in diabetes--2011.

Authors: 
Journal:  Diabetes Care       Date:  2011-01       Impact factor: 19.112

Review 3.  Epidemiology of hypertensive kidney disease.

Authors:  Suneel Udani; Ivana Lazich; George L Bakris
Journal:  Nat Rev Nephrol       Date:  2010-11-16       Impact factor: 28.314

Review 4.  Masked hypertension: a common but insidious presentation of hypertension.

Authors:  D W McKay; Martin G Myers; Peter Bolli; Arun Chockalingam
Journal:  Can J Cardiol       Date:  2006-05-15       Impact factor: 5.223

5.  Highlights and summary of the 2006 Canadian Hypertension Education Program recommendations.

Authors:  R M Touyz
Journal:  Can J Cardiol       Date:  2006-05-15       Impact factor: 5.223

Review 6.  Self-measurement of blood pressure at home in the management of hypertension.

Authors:  Hilde Celis; Elly Den Hond; Jan A Staessen
Journal:  Clin Med Res       Date:  2005-02

Review 7.  Clinical significance of home blood pressure and its possible practical application.

Authors:  Yutaka Imai
Journal:  Clin Exp Nephrol       Date:  2013-07-03       Impact factor: 2.801

8.  Standards of medical care in diabetes--2013.

Authors: 
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112

9.  A pharmacist intervention for monitoring and treating hypertension using bidirectional texting: PharmText BP.

Authors:  Linnea A Polgreen; Barry L Carter; Philip M Polgreen; Peter M Snyder; Daniel K Sewell; Emine O Bayman; Shelby L Francis; Jacob E Simmering; Christopher Parker; Rachel Finkelstein
Journal:  Contemp Clin Trials       Date:  2020-10-07       Impact factor: 2.226

10.  IMPPACT: Investigation of Medical Professionals and Patients Achieving Control Together.

Authors:  Sheldon W Tobe; Katie Hunter; Ryan Geerts; Nicholas Raymond; George Pylypchuk
Journal:  Can J Cardiol       Date:  2008-03       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.